Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel A Lawrence

Showing results (21-30 of 135) with videos related to

Pageof 14
Sort By:
Arteriosclerosis, Thrombosis, and Vascular Biology|March 27, 2025
PA System in the Pathogenesis of Ischemic StrokeBoxin Zhang, Lisa Leung, Enming J Su, et al.
Blood|July 9, 2005
A specific role of integrin Mac-1 in accelerated macrophage efflux to the lymphaticsChunzhang Cao, Daniel A Lawrence, Dudley K Strickland, et al.
Protein Science : a Publication of the Protein Society|April 23, 2002
Structural similarity of the covalent complexes formed between the serpin plasminogen activator inhibitor-1 and the arginine-specific proteinases trypsin, LMW u-PA, HMW u-PA, and t-PA: use of site-specific fluorescent probes of local environmentMarija Backovic, Efstratios Stratikos, Daniel A Lawrence, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|January 2, 2007
Molecular regulation of the PAI-1 gene by hypoxia: contributions of Egr-1, HIF-1alpha, and C/EBPalphaHui Liao, Matthew C Hyman, Daniel A Lawrence, et al.
American Journal of Physiology. Renal Physiology|July 24, 2009
Mechanisms underlying the antifibrotic properties of noninhibitory PAI-1 (PAI-1R) in experimental nephritisYufeng Huang, Wayne A Border, Daniel A Lawrence, et al.
Seminars in Thrombosis and Hemostasis|December 23, 2021
Tissue Plasminogen Activator in Central Nervous System Physiology and Pathology: From Synaptic Plasticity to Alzheimer's DiseaseTamara K Stevenson, Shannon J Moore, Geoffrey G Murphy, et al.
The Journal of Biological Chemistry|April 26, 2008
Structural differences between active forms of plasminogen activator inhibitor type 1 revealed by conformationally sensitive ligandsShih-Hon Li, Natalia V Gorlatova, Daniel A Lawrence, et al.
Brain : a Journal of Neurology|June 14, 2003
Impaired fibrinolysis in multiple sclerosis: a role for tissue plasminogen activator inhibitorsDjordje Gveric, Blanca Herrera, Axel Petzold, et al.
Oligonucleotides|March 17, 2009
Antimetastatic potential of PAI-1-specific RNA aptamersCharlene M Blake, Bruce A Sullenger, Daniel A Lawrence, et al.
Experimental Physiology|January 21, 2014
A plasminogen activator inhibitor type 1 mutant retards diabetic nephropathy in db/db mice by protecting podocytesJiandong Zhang, Chunyan Gu, Daniel A Lawrence, et al.
Pageof 14

Showing results (21-30 of 135) with videos related to

Sort By:
Pageof 14
Arteriosclerosis, Thrombosis, and Vascular Biology|March 27, 2025
PA System in the Pathogenesis of Ischemic StrokeBoxin Zhang, Lisa Leung, Enming J Su, et al.
Blood|July 9, 2005
A specific role of integrin Mac-1 in accelerated macrophage efflux to the lymphaticsChunzhang Cao, Daniel A Lawrence, Dudley K Strickland, et al.
Protein Science : a Publication of the Protein Society|April 23, 2002
Structural similarity of the covalent complexes formed between the serpin plasminogen activator inhibitor-1 and the arginine-specific proteinases trypsin, LMW u-PA, HMW u-PA, and t-PA: use of site-specific fluorescent probes of local environmentMarija Backovic, Efstratios Stratikos, Daniel A Lawrence, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|January 2, 2007
Molecular regulation of the PAI-1 gene by hypoxia: contributions of Egr-1, HIF-1alpha, and C/EBPalphaHui Liao, Matthew C Hyman, Daniel A Lawrence, et al.
American Journal of Physiology. Renal Physiology|July 24, 2009
Mechanisms underlying the antifibrotic properties of noninhibitory PAI-1 (PAI-1R) in experimental nephritisYufeng Huang, Wayne A Border, Daniel A Lawrence, et al.
Seminars in Thrombosis and Hemostasis|December 23, 2021
Tissue Plasminogen Activator in Central Nervous System Physiology and Pathology: From Synaptic Plasticity to Alzheimer's DiseaseTamara K Stevenson, Shannon J Moore, Geoffrey G Murphy, et al.
The Journal of Biological Chemistry|April 26, 2008
Structural differences between active forms of plasminogen activator inhibitor type 1 revealed by conformationally sensitive ligandsShih-Hon Li, Natalia V Gorlatova, Daniel A Lawrence, et al.
Brain : a Journal of Neurology|June 14, 2003
Impaired fibrinolysis in multiple sclerosis: a role for tissue plasminogen activator inhibitorsDjordje Gveric, Blanca Herrera, Axel Petzold, et al.
Oligonucleotides|March 17, 2009
Antimetastatic potential of PAI-1-specific RNA aptamersCharlene M Blake, Bruce A Sullenger, Daniel A Lawrence, et al.
Experimental Physiology|January 21, 2014
A plasminogen activator inhibitor type 1 mutant retards diabetic nephropathy in db/db mice by protecting podocytesJiandong Zhang, Chunyan Gu, Daniel A Lawrence, et al.
Pageof 14